NanoString Technologies, Inc. (NSTG)
Stock analysis · NASDAQ · Healthcare · Medical - Instruments & Supplies
NanoString Technologies, Inc. (NSTG) is a publicly traded company in the Healthcare sector. Latest price: $0.11. Market cap $5.07M. Trailing PE -0.03. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Proprietary Signals
About NanoString Technologies, Inc.
NanoString Technologies, Inc. is a global innovator in scientific instrumentation, designing and producing advanced research tools for genomics and proteomics across the Americas, Europe, the Middle East, and Asia Pacific. Its flagship offering is the nCounter Analysis System, an automated platform renowned for its versatile digital detection and counting capabilities. This system includes both nCounter MAX and FLEX configurations, which integrate a Prep Station for automated liquid handling and sample preparation, alongside a Digital Analyzer. The Analyzer captures data by imaging fluorescent reporters within sample cartridges, then processes this information into usable output files. The company also offers the nCounter SPRINT Profiler, a compact instrument that streamlines liquid handling and digital analysis using a specialized microfluidic cartridge. Complementing its hardware, NanoString provides nSolver Analysis Software, a powerful program enabling researchers to verify, normalize, and interpret their experimental data. Further extending its product portfolio, NanoString supplies customizable CodeSets and pre-designed panels tailored for applications in oncology, immunolog…
Valuation
| P/E (TTM) | -0.03× |
|---|---|
| P/S (TTM) | 0.04× |
| P/B | 0.11× |
| PEG | 0.00× |
| P/FCF (TTM) | -0.03× |
| EV / EBITDA | -1.00× |
| EV / Sales | 1.13× |
| Earnings Yield | -3264.94% |
| Free Cash Flow Yield | -2993.41% |
Fundamentals
| Enterprise Value | $143.32M |
|---|---|
| Revenue (TTM) | $127.26M |
| Net Income (TTM) | -$165.43M |
| Free Cash Flow (TTM) | -$135.42M |
| Net Debt | $138.25M |
| Working Capital | $227.91M |
| Gross Margin | 48.55% |
| Operating Margin | -119.58% |
| Net Margin | -125.37% |
| Return on Equity | -143.23% |
| Return on Invested Capital | -50.72% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap